Concepedia

Claudia Iavarone

CI

5

Publications

266

Citations

5

H-Index

2016

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Johns Hopkins University

University of Pennsylvania

Claudia Iavarone is an author at Harvard University specializing in molecular oncology, ovarian cancer, and cancer therapeutics.

Top concepts

Publications per year

2016–2020

5

Publications

5

Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response

Ioannis K. Zervantonakis, Claudia Iavarone, Hsing‐Yu Chen et al. · Nature Communications · 2017 · 74 citations · Full text

Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition

Marcin Iwanicki, Hsing‐Yu Chen, Claudia Iavarone et al. · JCI Insight · 2016 · 60 citations · Full text

Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness

Claudia Iavarone, Ioannis K. Zervantonakis, Laura M. Selfors et al. · Molecular Cancer Therapeutics · 2019 · 53 citations

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

Robert C. Bast, Ursula A. Matulonis, Anil K. Sood et al. · Cancer · 2019 · 52 citations · Full text

, , +20

A self-sustaining endocytic-based loop promotes breast cancer plasticity leading to aggressiveness and pro-metastatic behavior

Irene Schiano Lomoriello, Giovanni Giangreco, Claudia Iavarone et al. · Nature Communications · 2020 · 27 citations · Full text

Rows per page

1–5 of 5